Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Concordia Healthcare completes acquiring Covis Pharma assets in a $1.2bn deal
Thursday, April 23, 2015Concordia Healthcare has completed the acquisition of branded and authorized generic products from Covis Pharma and Covis Injectables collectively Covis for bn These products include branded products five authorized generic contracts and a product...
Breast cancer drugs boost Q1 sales at Swiss pharmaceutical company Roche
Thursday, April 23, 2015Breast cancer drugs such as Herceptin as well as new uses for multicancer drug Avastin helped Swiss pharmaceutical firm Roche grow sales by percent during the first quarter Group sales rose percent to billion Swiss francs billion Sales rose per...
Scientists to share real-time genetic data on deadly MERS, Ebola
Thursday, April 23, 2015Genetic sequence data on two of the deadliest yet most poorly understood viruses are to be made available to researchers worldwide in real time as scientists seek to speed up understanding of Ebola and MERS infections The project led by British scie...
Perrigo Board Rejects Mylan’s Unsolicited $28.9 Billion Proposal
Wednesday, April 22, 2015Perrigo Cos board unanimously rejected Mylan NVs billion takeover proposal saying it doesnt reflect the value of the overthecounter drug companys growth potential Continued execution by the management team against our global growth strategy will de...
Ariad Pharmaceuticals announces the issuance of U.S. patent on brigatinib, ALK inhibitor
Wednesday, April 22, 2015ARIAD Pharmaceuticals Inc NASDAQ ARIA today announced the issuance of its first US patent on brigatinib ARIADs investigational ALK inhibitor The United States Patent and Trademark Office granted US Patent No under the title Phosphorous Derivatives a...
Erytech Pharma strengthens its intellectual property position in the US
Wednesday, April 22, 2015Erytech strengthens its intellectual property position in the US Patent covering ERYASP in pancreatic cancer granted in US Term of core encapsulation patent further extended until It covers use of ERYASP Erytechs lead product for treatment of pan...
Regen BioPharma engages Charles River to initiate FDA-requested study with regard to HemaXellerate
Wednesday, April 22, 2015Regen BioPharma Inc OTCBB RGBP OTC PINK RGBP announced today that it has engaged Charles River Laboratories to initiate a Good Laboratory Practices GLP mouse toxicity study with regards to HemaXellerate HemaXellerate a therapy under development by Re...
Taiwan's Food and Drug Administration to set up pharmaceutical ingredient recording system
Tuesday, April 21, 2015A system for recording pharmaceutical raw materials will be put online in which manufacturers will be obliged to record their ingredients in the second half of this year before the system is officially launched next year Taiwans Food and Drug Adminis...
Teva agrees to pay $512 million to resolve charges of keeping generic manufacturers off the market
Tuesday, April 21, 2015Teva Pharmaceutical Industries Ltd will pay million to resolve a classaction lawsuit accusing the drugmaker of conspiring to delay sales of generic versions of its sleepdisorder medicine Provigil ending almost a decade of litigation Cephalon Inc wh...
Acacia Pharma starts phase 3 study investigating APD421 in combination with anti-emetics for PONV
Tuesday, April 21, 2015An international study is underway utilising a potential therapy from Cambridge healthcare technology business Acacia Pharma to fight postoperative nausea and vomiting PONV in highrisk patients Acacias APD is being trialled in combination with standa...
